Nanjing MeiRui Pharma

Showing 1 posts of 1 posts found.

GSK acquires China’s Nanjing MeiRui Pharma for $70m

December 8, 2010
Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing

GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …

The Gateway to Local Adoption Series

Latest content